Hematologic Diseases
4
Pipeline Programs
9
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
9 companies ranked by most advanced pipeline stage
Acrotech BiopharmaNJ - East Windsor
1 program1
Vincristine Sulfate LiposomePhase 11 trial
Active Trials
GS
Gilead SciencesFOSTER CITY, CA
2 programsNewSpringForMe digital solutionN/A1 trial
NewSpringForMe digital solutionN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
RallybioRLYB116 for Injection
MaaT PharmaMaaT033 capsule
Acrotech BiopharmaVincristine Sulfate Liposome
Gilead SciencesNewSpringForMe digital solution
Heidelberg Pharmaex-vivo drug response assay
Clinical Trials (5)
Total enrollment: 266 patients across 5 trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants
Start: Apr 2025Est. completion: Feb 202616 patients
Phase 1Completed
Safety and Tolerability Evaluation of MaaT033
Start: Oct 2020Est. completion: Dec 2021
Phase 1Completed
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Start: Aug 2020Est. completion: Oct 2020
Phase 1Unknown
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Start: Sep 2022Est. completion: Dec 2024170 patients
N/AUnknown
Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer
Start: Apr 2018Est. completion: Aug 202180 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
9 companies competing in this space